Found 1 clinical trials
A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
Phase I, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of HMPL-306 in Patients of Relapsed/Refractory Myeloid Leukemia/Neoplasms with IDH1 and/or IDH2 Mutation.
IDH2
myelodysplastic syndromes
myeloid neoplasm
idh2 gene mutation
refractory acute myeloid leukemia (aml)
- 0 views
- 16 Feb, 2024
- 1 location